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The significance of  managing Human Immunodeficiency 
Virus (HIV) and reducing the risk of  non-communicable 
diseases (NCDs) is vital to the health and development 
of  Africa given that;1) ART therapy can lead to metabolic 
complications;[1] 2) NCDs, particularly cardiovascular 
disease (CVD), are on the rise in Africa;[2,3] 3) HIV 
is more prevalent in vulnerable populations;[4,5] 4) 
Rwandan citizens have survived one of  the most violent 
genocides in history;[6] 5) many children, who are now 
young adults, were orphaned by genocide; and 6) bio-
behavioral research is necessary and feasible in Rwanda.
[7] There were approximately 36.7 million individuals 
with HIV worldwide in 2016.[5] By 2017, only 20.9 
million (56.9%) were receiving antiretroviral therapy 
(ART)[5]. The vast majority of  these persons are living 
in sub-Saharan Africa. Despite advances in scientific 
knowledge of  HIV prevention and treatment, too many 
people with HIV do not have basic access to prevention 
measures, care, treatments, and there is still no cure.[5] 
The consequences of  HIV are not limited to the health 
of  the individual but affect households, communities, 
and the economic growth of  nations.[5] Despite this, 
there has been a decline in new HIV infections and an 
increase in treatment coverage. However, these positive 
results are tempered by burgeoning NCD rates.[8]
Africa faces substantial challenges due to persistent 
infectious diseases and escalating NCDs.[8] NCDs kill 
40 million people worldwide each year comprising 70% 
of  all deaths.[9] The majority of  these deaths are from 
CVD (44%).[2] Approximately 13% of  those deaths 
occurred in Africa. The World Health Organization 
(WHO) estimates that by 2030, NCDs will afflict 
55 million persons worldwide, with low and middle-
income countries in Africa bearing the largest burden.
[9] In 2011, the United Nations recommended a “5 by 
5” strategy for the prevention and control of  NCDs. 
The strategy is based on 5 risk factors and 5 NCDs 
responsible for 80% of  all deaths. The five risk factors 
including; 1) tobacco use, 2) unhealthy diet, 3) physical 
inactivity, 4) harmful use of  alcohol, and 5) transmissible 
diseases such as HIV.[10] The five major NCDs are; 
1) CVD, 2) cancer, 3) chronic respiratory diseases, 4) 
diabetes, and 5) neuropsychiatric disorders.  In order 
to reduce NCDs, Nyirenda noted that scientists must 
have a better understanding of  the drivers of  NCDs 
including both traditional and emerging risk factors such 
as the influence of  insults early in life or interactions 
with infections.[3]
An understudied and underdiagnosed problem, 
particularly in Africa, consists of  persons with mental 
illnesses. Those with mental illness are at increased 
risk for coexisting physical health problems including 
CVD. For those who are diagnosed and treated for 
mental illness, psychiatric medications, especially 
antipsychotics, are often associated with side effects. 
One of  the primary side effects is excessive weight gain. 
Obesity is a well-known risk for CVD in the mentally ill 
patient population.[11]
The 1994 Rwandan Genocide against the Tutsi was the 
quickest, most violent genocide in history, resulting in 
the deaths on nearly one million Rwandans.[12] Rwandan 
families and communities continue to be affected 
by heightened stressors such as HIV, poverty, and a 
growing substance abuse issue.[13,14] Mental Health 
concerns related to trauma or stressors in adolescence 
and adulthood increase the risk for depression, 
anxiety, post-traumatic stress disorder, high-risk sexual 
behaviors, low self-esteem, social isolation, drug and 
substance abuse.[15]
Cardiovascular diseases have emerged as one of  the 
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most common causes of  death in individuals with 
HIV.[16] Clinical CVD appears approximately 10 
years earlier in those with HIV compared to those 
without HIV. The pathogenesis behind these early 
complications is complex and is hypothesized to 
involve immune activation, chronic inflammation, and 
metabolic disorders; factors associated with the virus 
itself.[16] Rates of  CVD have plateaued in the US, after 
falling since 1984, and are expected to rise by 18% by 
2030, mostly due to the obesity and type 2 diabetes 
epidemics.[17] A reduction in CVD has the potential 
to improve quality of  life,[18] physical functioning,[19] 
and reduce mortality. Given the burden of  morbidity 
and mortality caused by communicable diseases (such 
as HIV) and NCDs, the authors have developed a cross-
cultural collaboration to study the risk factors that may 
contribute to early onset CVD in patients with HIV. 
This collaboration was made possible by a Fulbright 
US Scholar award to the first author. The authors 
are actively working to build the expertise of  the 
multidisciplinary research team by including mental 
health experts, nurses, physicians, and basic scientists 
to conduct research in Rwanda and the US in order to 
contribute to the science of  HIV and NCDs, to provide 
an evidence-base for practice, and to determine what 
similarities and differences exist across the two cultures. 
The data from this pilot work will be used to expand our 
studies to examine other NCDs such as chronic kidney 
disease and hypertension, other significant health issues 
in Rwanda and the US. 
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